Risk score model yielded nearly 100 percent prediction accuracy of 13-year dementia risk
Neuropsychiatric conditions and/or associated treatment linked to increased risk for severe outcomes from COVID-19, SARIs
The two most common, valproic acid and gabapentin, being used in clinically distinct ways
Education found to be an important statistical factor contributing to the reduction in dementia
Those with a family history or higher self-perceived risk are more likely to participate
However, treatment lowers risk of dementia among older adults
Compared with matched controls without dementia, improvement, recovery less likely for people living with dementia
Risk for dementia reduced with each additional year of education; dementia prevalence higher for Blacks
Dementia risk more than doubled compared with people without psychotic disorders
Findings seen among middle-aged and older adults without cognitive impairment or Parkinson disease at baseline